- Home
- CRGX vs CYH Comparison
CRGX vs CYH Comparison
Compare CRGX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- CYH
- Stock Information
- Founded
- CRGX 2021
- CYH 1985
- Country
- CRGX United States
- CYH United States
- Employees
- CRGX N/A
- CYH N/A
- Industry
- CRGX
- CYH Hospital/Nursing Management
- Sector
- CRGX
- CYH Health Care
- Exchange
- CRGX Nasdaq
- CYH Nasdaq
- Market Cap
- CRGX 621.4M
- CYH 623.8M
- IPO Year
- CRGX 2023
- CYH 1991
- Fundamental
- Price
- CRGX $13.46
- CYH $3.42
- Analyst Decision
- CRGX Strong Buy
- CYH Hold
- Analyst Count
- CRGX 6
- CYH 6
- Target Price
- CRGX $31.80
- CYH $4.40
- AVG Volume (30 Days)
- CRGX 235.6K
- CYH 1.7M
- Earning Date
- CRGX 03-20-2025
- CYH 02-18-2025
- Dividend Yield
- CRGX N/A
- CYH N/A
- EPS Growth
- CRGX N/A
- CYH N/A
- EPS
- CRGX N/A
- CYH N/A
- Revenue
- CRGX N/A
- CYH $12,551,000,000.00
- Revenue This Year
- CRGX N/A
- CYH $1.16
- Revenue Next Year
- CRGX N/A
- CYH $1.18
- P/E Ratio
- CRGX N/A
- CYH N/A
- Revenue Growth
- CRGX N/A
- CYH 0.81
- 52 Week Low
- CRGX $10.91
- CYH $2.51
- 52 Week High
- CRGX $33.92
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- CRGX 47.00
- CYH 60.10
- Support Level
- CRGX $12.51
- CYH $2.88
- Resistance Level
- CRGX $15.75
- CYH $3.04
- Average True Range (ATR)
- CRGX 1.09
- CYH 0.14
- MACD
- CRGX 0.17
- CYH 0.08
- Stochastic Oscillator
- CRGX 52.74
- CYH 99.12
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.